Appointment of Directors
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd has announced significant board changes effective October 8, 2025. Two new independent directors — Ms. Ritu Tiwari and Ms. Nikita Sinha — have been appointed as Additional (Non-Executive, Independent) Directors for a 5-year term, subject to shareholder approval. Both bring company secretarial and compliance experience. On the same day, Mr. Bangalore Venkatakrishnappa Ananth Kumar (Whole-Time / Executive Director) and Mrs. Ananthkumar Shilpa (Non-Executive Independent Director) resigned citing personal reasons. The Managing Director (Mr. Nanjappan Aravind) remains in place.
The exit of the Whole-Time Director and one Independent Director alongside the entry of two new Independent Directors signals a notable board reshuffle. For shareholders, this means monitoring continuity of operations during the leadership transition and watching for shareholder approval outcomes at the next general meeting.